Appropriation of the Connected Solution Freestyle Libre® in Adult Patients With Diabetes in the Context of Therapeutic Education
NCT ID: NCT04739124
Last Updated: 2023-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
86 participants
OBSERVATIONAL
2021-06-10
2023-09-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System
NCT03411460
FreeStyle Libre Monitoring in T2DM
NCT05597293
Freestyle Libre Use in Real Life: Efficacy and Acceptance
NCT03703999
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
NCT03502174
Accuracy of Freestyle Libre
NCT02734745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic patients
Patients presenting type 1 or type 2 diabetes, eligible for the prescription of Freestyle Libre
Follow-up questionnaires
The patient normally follows the education program as usual but research specific data is collected:
* Biological sampling at the start and end of the education program (glycated hemoglobin).
* Retrieval of usage and glycemic balance data from the Libreview online platform (at one week, one month and three months of use)
* Iterative questionnaires allowing the study of factors of acceptance, appropriation and use (at the start of the study, at 4 weeks, at 12 weeks)
Interviews
Semi-structured interviews will be carried out during the visits, either face-to-face or remotely.
Caregivers
Caregiver caring for diabetic patients and practicing therapeutic education on a regular basis
Follow-up questionnaires
The patient normally follows the education program as usual but research specific data is collected:
* Biological sampling at the start and end of the education program (glycated hemoglobin).
* Retrieval of usage and glycemic balance data from the Libreview online platform (at one week, one month and three months of use)
* Iterative questionnaires allowing the study of factors of acceptance, appropriation and use (at the start of the study, at 4 weeks, at 12 weeks)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow-up questionnaires
The patient normally follows the education program as usual but research specific data is collected:
* Biological sampling at the start and end of the education program (glycated hemoglobin).
* Retrieval of usage and glycemic balance data from the Libreview online platform (at one week, one month and three months of use)
* Iterative questionnaires allowing the study of factors of acceptance, appropriation and use (at the start of the study, at 4 weeks, at 12 weeks)
Interviews
Semi-structured interviews will be carried out during the visits, either face-to-face or remotely.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have type 1 or type 2 diabetes (as included in the education program),
* Be of legal age (over 18 years old),
* Do not present legal protection measures due to incapacity (such as guardianship or guardianship).
* Be able to read and speak French (elementary school level)
* Be eligible for FSL prescription and authorize the sharing of your data in Libreview®
* Be affiliated to a social security scheme
* Have an email address or a phone allowing internet use
* Caregivers
* Be registered on the roll of his professional order
* Hold the certificate of 40 hours of training in therapeutic education.
* Practice therapeutic education on a regular basis
Exclusion Criteria
* presenting contraindications to the use of Freestyle Libre® (known allergies to adhesive products, coagulation disorders, not treated with insulin therapy or with less than 3 insulin injections per day or continuously, not requiring glycemic monitoring or less than 3 times a day)
* Patient refusing to follow the education program,
* Minors, patients under administrative or judicial supervision)
* Pregnant women,
* Patients who cannot be contacted in an emergency,
* Persons in a position to give their consent but with an inability to read / write the French language.
* Patients who do not have an email address or a phone allowing internet use.
* Caregivers
* Failure to register with the professional order (except those of the Army Health Service who are exempt)
* Non-possession of the 40-hour therapeutic education training certificate.
* Not practicing FSL education
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Avicenne
Bobigny, , France
Hopital d'Instruction des Armées Bégin
Saint-Mandé, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020PPRC11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.